Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
The structure-activity relationship of a novel series of substituted piperazinone-based factor Xa inhibitors is described. The most potent compound 34 displays IC(50) of 0.9 nM.